181 related articles for article (PubMed ID: 16847584)
1. Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy.
Chapple CR; Brubaker L; Haab F; van Kerrebroeck P; Robinson D
Int Urogynecol J Pelvic Floor Dysfunct; 2007 Feb; 18(2):199-205. PubMed ID: 16847584
[TBL] [Abstract][Full Text] [Related]
2. Urethral injection therapy for urinary incontinence in women.
Kirchin V; Page T; Keegan PE; Atiemo KO; Cody JD; McClinton S; Aluko P
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD003881. PubMed ID: 28738443
[TBL] [Abstract][Full Text] [Related]
3. Stress incontinence injection therapy: what is best for our patients?
Chapple CR; Wein AJ; Brubaker L; Dmochowski R; Pons ME; Haab F; Hill S
Eur Urol; 2005 Oct; 48(4):552-65. PubMed ID: 16118034
[TBL] [Abstract][Full Text] [Related]
4. An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence.
Chapple CR; Haab F; Cervigni M; Dannecker C; Fianu-Jonasson A; Sultan AH
Eur Urol; 2005 Sep; 48(3):488-94. PubMed ID: 15967568
[TBL] [Abstract][Full Text] [Related]
5. [Urethral Macroplastique injection as a treatment for female stress incontinence].
Sander P; Mouritsen AL; Lose G
Ugeskr Laeger; 2004 Aug; 166(36):3100-2. PubMed ID: 15387310
[No Abstract] [Full Text] [Related]
6. Urethral injection for stress urinary incontinence: long-term results with dextranomer/hyaluronic acid copolymer.
Stenberg AM; Larsson G; Johnson P
Int Urogynecol J Pelvic Floor Dysfunct; 2003 Nov; 14(5):335-8; discussion 338. PubMed ID: 14618311
[TBL] [Abstract][Full Text] [Related]
7. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence.
Bano F; Barrington JW; Dyer R
Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(2):147-50; discussion 150. PubMed ID: 15378234
[TBL] [Abstract][Full Text] [Related]
8. Can Urethral Bulking Agents Salvage Failed Slings?
Dray EV; Hall M; Covalschi D; Cameron AP
Urology; 2019 Feb; 124():78-82. PubMed ID: 30412703
[TBL] [Abstract][Full Text] [Related]
9. Periurethral non-animal stabilized hyaluronic acid/dextranomer injections: efficacy and formation of granuloma/sterile abscess.
Sahai A; Thomas M; Nedas T; Larner T; Niekrash R; Hammadeh MY
Urology; 2009 Sep; 74(3):486-8. PubMed ID: 19586653
[No Abstract] [Full Text] [Related]
10. [Paraurethral abscess developing after mid-urethral Zuidex-injection in women with stress urinary incontinence -- management of complications and retrospective comparison with bladder neck located injection technique].
Hagemeier T; Blau U; Gauruder-Burmester A; Tunn R
Zentralbl Gynakol; 2006 Apr; 128(2):68-70. PubMed ID: 16673247
[TBL] [Abstract][Full Text] [Related]
11. Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence.
Corcos J; Collet JP; Shapiro S; Herschorn S; Radomski SB; Schick E; Gajewski JB; Benedetti A; MacRamallah E; Hyams B
Urology; 2005 May; 65(5):898-904. PubMed ID: 15882720
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically.
Lightner D; Rovner E; Corcos J; Payne C; Brubaker L; Drutz H; Steinhoff G;
Urology; 2009 Oct; 74(4):771-5. PubMed ID: 19660800
[TBL] [Abstract][Full Text] [Related]
13. Simple aspiration technique to address voiding dysfunction associated with transurethral injection of dextranomer/hyaluronic acid copolymer.
Petrou SP; Pak RW; Lightner DJ
Urology; 2006 Jul; 68(1):186-8. PubMed ID: 16777199
[TBL] [Abstract][Full Text] [Related]
14. Obstructive suburethral mass after transurethral injection of dextranomer/hyaluronic acid copolymer.
Abdelwahab HA; Ghoniem GM
Int Urogynecol J Pelvic Floor Dysfunct; 2007 Nov; 18(11):1379-80. PubMed ID: 17437054
[TBL] [Abstract][Full Text] [Related]
15. Obstructive suburethral mass following injection of dextranomer/hyaluronic acid copolymer.
Fatton B; Savary D; Velemir L
Int J Gynaecol Obstet; 2009 Jan; 104(1):73-4. PubMed ID: 18926538
[No Abstract] [Full Text] [Related]
16. Bulking agents: an analysis of 500 cases and review of the literature.
Mohr S; Siegenthaler M; Mueller MD; Kuhn A
Int Urogynecol J; 2013 Feb; 24(2):241-7. PubMed ID: 22707004
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of transurethral injection of hyaluronic acid/dextranomer (NASHA/Dx gel) for the treatment of stress urinary incontinence (SUI).
Lone F; Sultan AH; Thakar R
Int Urogynecol J; 2010 Nov; 21(11):1359-64. PubMed ID: 20571764
[TBL] [Abstract][Full Text] [Related]
18. Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes.
Lightner DJ; Fox J; Klingele C
Urology; 2010 Jun; 75(6):1310-4. PubMed ID: 20299087
[TBL] [Abstract][Full Text] [Related]
19. Effects of Macroplastique Implantation System for stress urinary incontinence and urethral hypermobility in women.
ter Meulen PH; Berghmans LC; Nieman FH; van Kerrebroeck PE
Int Urogynecol J Pelvic Floor Dysfunct; 2009 Feb; 20(2):177-83. PubMed ID: 18936867
[TBL] [Abstract][Full Text] [Related]
20. Current role of injectable agents for female stress urinary incontinence.
Herschorn S
Can J Urol; 2006 Feb; 13 Suppl 1():5-12. PubMed ID: 16526974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
